Aveanna Healthcare Raises 2026 Guidance on Strong Q2 Growth
Event summary
- Aveanna Healthcare reported Q2 2026 revenue of $670.5 million, up 13.7% YoY.
- Net income increased to $40.3 million from $27.0 million in the prior year period.
- Adjusted EBITDA grew by 8.0% YoY to $95.4 million.
- Full-year 2026 revenue guidance raised to over $2.68 billion, up from $2.63-$2.65 billion.
- Adjusted EBITDA guidance increased to over $365 million, up from $338-$342 million.
The big picture
Aveanna Healthcare's strong Q2 2026 results reflect its ability to deliver consistent year-over-year growth across all segments. The company's strategic initiatives, including the Preferred Payor and Government Affairs strategies, are reinforcing its operating model. With increased full-year guidance, Aveanna is positioning itself for sustained performance in the home care market.
What we're watching
- Organic Growth Momentum
- How Aveanna's sustained growth across all three business segments will impact its market position.
- Strategic Initiatives
- Whether the Preferred Payor and Government Affairs strategies can continue driving performance.
- Integration Success
- The pace at which Aveanna can successfully integrate acquisitions like Family First to maintain growth trajectory.